Real World Evidence: Driving Decision Making in Oncology
04 December 2019
- Oncology prescribing practices rely heavily on the data from clinical trials. However, due to lesser patient numbers found in clinical trials, knowledge gaps start presenting themselves in the form of understanding disease progression, overall survival, efficacy etc.
- Information like this can be collected in real world evidence studies so that more personalised treatment pathways can be found.
- Real-world evidence study outcomes don’t always align to RCTs, meaning they provide novel data sets that can support RCT data
Click here to read the source article
SVMPharma – Running real-world immuno-oncology outcome studies
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.
For more information, please visit www.svmpharma.com and contact us at email@example.com